Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | PRNP | P04156 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11779440 | 0.94 | ALDH1A1 (0.35) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL33145 | 0.75 | ALDH1A1 (0.43) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL2725593 | 0.71 | TSHR (0.42) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL18120548 | 0.69 | CYP1A2 (0.47) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL10637349 | 0.67 | ALDH1A1 (0.50) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL8595031 | 0.66 | LMNA (0.52) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL8656719 | 0.65 | LMNA (0.48) | MAPTHTTRECQLCYP1A2LMNA | |
| SCHEMBL3517644 | 0.65 | MEN1 (0.32) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL8844371 | 0.65 | GAA (0.47) | MEN1KMT2AATMMAPTTSHR | |
| SCHEMBL1131131 | 0.65 | GAA (0.47) | MEN1KMT2AATMMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | POF1B, CYP4F12, ETFB | MEN1 3131/4885KMT2A 2319/4885ATM 4787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.